Irukayama-Tomobe, Y., Ogawa, Y., Tominaga, H., Ishikawa, Y., Hosokawa, N., Ambai, S., . . . Yanagisawa, M. (2017). Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models. Proc Natl Acad Sci U S A.
Chicago Style CitationIrukayama-Tomobe, Yoko, et al. "Nonpeptide Orexin Type-2 Receptor Agonist Ameliorates Narcolepsy-cataplexy Symptoms in Mouse Models." Proc Natl Acad Sci U S A 2017.
Cita MLAIrukayama-Tomobe, Yoko, et al. "Nonpeptide Orexin Type-2 Receptor Agonist Ameliorates Narcolepsy-cataplexy Symptoms in Mouse Models." Proc Natl Acad Sci U S A 2017.
Atenció: Aquestes cites poden no estar 100% correctes.